| # | Drug | Count |
|---|---|---|
| 0 | INFLIXIMAB-DYYB | 163 |
| 1 | INFLIXIMAB | 28 |
| 2 | PANTOPRAZOLE | 26 |
| 3 | ERGOCALCIFEROL | 20 |
| 4 | PREDNISONE | 19 |
| 5 | ACETAMINOPHEN | 13 |
| 6 | DIPHENHYDRAMINE HYDROCHLORIDE | 12 |
| 7 | LEVOTHYROXINE SODIUM | 11 |
| 8 | PANTOPRAZOLE SODIUM | 11 |
| 9 | PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE | 11 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | USTEKINUMAB-STBA | 2 | 0.0075 |
| 1 | INFLIXIMAB-DYYB | 163 | 0.0056 |
| 2 | COLESEVELAM | 3 | 0.0029 |
| 3 | TRANDOLAPRIL TABLETS | 1 | 0.0005 |
| 4 | PERINDOPRIL ERBUMINE | 2 | 0.0004 |
| 5 | HYDROCORTISONE SODIUM SUCCINATE | 3 | 0.0003 |
| 6 | DIMENHYDRINATE | 3 | 0.0003 |
| 7 | DIFLUPREDNATE | 1 | 0.0003 |
| 8 | SILODOSIN | 1 | 0.0003 |
| 9 | CHOLESTYRAMINE | 3 | 0.0002 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 176 |
| 1 | Corticosteroid [EPC] | 28 |
| 2 | Provitamin D2 Compound [EPC] | 20 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 17 |
| 4 | Calcium [EPC] | 10 |
| 5 | Factor Xa Inhibitor [EPC] | 10 |
| 6 | Aminosalicylate [EPC] | 9 |
| 7 | Purine Antimetabolite [EPC] | 8 |
| 8 | Platelet Aggregation Inhibitor [EPC] | 7 |
| 9 | Benzodiazepine [EPC] | 6 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Serotonin and Norepinephrine Reuptake Inhibitor [EPC] | 1 | 0.0003 |
| 1 | Bile Acid Sequestrant [EPC] | 3 | 0.0002 |
| 2 | Tumor Necrosis Factor Blocker [EPC] | 176 | 0.0002 |
| 3 | Progesterone [EPC] | 3 | 0.0001 |
| 4 | Thyroid Hormone Synthesis Inhibitor [EPC] | 1 | 0.0001 |
| 5 | Bile Acid [EPC] | 2 | 0.0001 |
| 6 | Calcitonin Gene-related Peptide Receptor Antagonist [EPC] | 1 | 0.0001 |
| 7 | Purine Antimetabolite [EPC] | 8 | 0.0001 |
| 8 | Alkaloid [EPC] | 2 | 0.0001 |
| 9 | Aminosalicylate [EPC] | 9 | 0.0001 |